KnowBe4 Shareholders May Have Legal Claims – KNBE

Kehoe Law Firm, P.C. is investigating whether the directors of KnowBe4, Inc. (“KnowBe4”) (NASDAQ: KNBE) breached their fiduciary duties to its shareholders in approving a buyout with funds affiliated with Vista Equity Partners (“Vista”) for inadequate consideration.
INVESTORS OF KNOWBE4 STOCK MAY HAVE LEGAL CLAIMS AND ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. 

The investigation concerns whether KnowBe4’s board of directors failed to maximize the value of KnowBe4 for the benefit of KnowBe4’s shareholders in connection with its announced buyout by funds affiliated with Vista, in breach of their fiduciary duties to KnowBe4’s shareholders, and whether KnowBe4’s shareholders have suffered damages as a result.

On October 12, 2022, KnowBe4 announced it had reached an agreement to be bought out by funds affiliated with Vista for $24.90 per share, in an all-cash transaction valued at approximately $4.6 billion.

INVESTORS OF KNOWBE4 STOCK ARE ENCOURAGED TO CONTACT EITHER JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected][email protected], TO DISCUSS THE INVESTIGATION OR POTENTIAL LEGAL CLAIMS.

KNOWBE4 (NASDAQ: KNBE) BREACH OF FIDUCIARY DUTIES INVESTIGATION

Long-Term Fox Shareholders May Have Legal Claims – FOX, FOXA

Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Fox Corporation (“Fox”) (NASDAQ: FOX, FOXA) breached their fiduciary duties to Fox and its shareholders.
FOX INVESTORS THAT HAVE HELD THEIR STOCK (FOX, FOXA) SINCE BEFORE FEBRUARY 2021 AND WHO WISH TO DISCUSS POTENTIAL LEGAL CLAIMS ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. 

The investigation concerns whether members of Fox’s board of directors or senior management failed to manage Fox in an acceptable manner, in breach of their fiduciary duties, and whether Fox and its shareholders have suffered damages as a result.

On February 4, 2021, Smartmatic USA Corporation (“Smartmatic”) filed a defamation lawsuit against Fox, alleging that Smartmatic suffered severe harm after numerous Fox News on-air personalities made misrepresentations about Smartmatic’s business in the wake of the November 2020 presidential election.

INVESTORS OF FOX STOCK SINCE BEFORE FEBRUARY 2021  ARE ALSO ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected][email protected], TO DISCUSS THE INVESTIGATION OR POTENTIAL LEGAL CLAIMS.

LONG-TERM FOX SHAREHOLDERS (NASDAQ: FOX, FOXA) ENCOURAGED TO CONTACT KEHOE LAW FIRM, P.C.

Lottery.com Shareholders Who Held TDAC Stock May Have Legal Claims

Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Trident Acquisitions Corp. (“Trident”) (NASDAQ: TDAC), now known as Lottery.com Inc. (“Lottery.com”) (NASDAQ: LTRY), breached their fiduciary duties to Trident’s shareholders.
LOTTERY.COM SHAREHOLDERS THAT OWNED TRIDENT ACQUISITIONS STOCK AND WHO WISH TO DISCUSS POTENTIAL LEGAL CLAIMS ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. 

The investigation concerns whether Trident’s board of directors or executive officers breached their duties of disclosure, duties of candor, and requirements to act in good faith, and whether Trident’s shareholders suffered damages as a result.

On October 28, 2021, Trident shareholders of record as of October 13, 2021 approved a merger between Trident and Lottery.com.

In July 2022, Lottery.com fired its Chief Financial Officer after accounting irregularities were uncovered. Not long after, Lottery.com’s Chief Revenue Officer resigned, after Lottery.com discovered “instances of non-compliance with state and federal laws concerning the state in which tickets are procured.” Lottery.com also announced it had overstated its cash holdings by $30 million. In September 2022, four directors resigned from Lottery.com’s board, with several directors claiming that Lottery.com thwarted their attempts to look into red flags at the company.

The stock price has declined by more than 99.7% since the merger.

LOTTERY.COM SHAREHOLDERS WHO OWNED TRIDENT ACQUISITIONS CORP. STOCK ARE ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected][email protected], TO DISCUSS THE INVESTIGATION OR POTENTIAL LEGAL CLAIMS.

LOTTERY.COM (NASDAQ: LTRY) INVESTORS WHO OWNED TRIDENT ACQUISITIONS STOCK ENCOURAGED TO CONTACT KEHOE LAW FIRM

 

 

Biogen Investors May Have Legal Claims – BIIB

Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Biogen Inc. (“Biogen”) (NASDAQ: BIIB) breached their fiduciary duties to Biogen and its shareholders. 
BIOGEN INVESTORS WHO HAVE HELD BIIB STOCK SINCE AT LEAST JANUARY 2022 ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS OF THEIR BIOGEN SECURITIES.  

The investigation concerns whether members of the Biogen Board of Directors (the “Biogen Board”) made, or caused Biogen to make, false and/or misleading statements, as well as failed to disclose material adverse facts, about Biogen’s business, operations, prospects, and financial health.

Kehoe Law Firm, P.C. is investigating whether the Biogen Board failed to disclose material information, including whether Biogen misled investors regarding: (a) the number of sites ready, willing, and able to administer Aduhelm immediately after approval; (b) the significance of logistical constraints on diagnosing patients; (c) the degree to which Medicare’s coverage of the treatment was independent of the FDA’s approval of the treatment; (d) the willingness of third-party payors to cover Aduhelm at a premium price point, or, indeed, at any price point absent peer-reviewed data supporting a determination of the treatment’s clinical effectiveness; and (e) the Veterans Health Administration’s willingness and capacity to cover and administer Aduhelm for its beneficiaries; and whether, as a result, statements about Biogen’s business, operations, and prospects lacked a reasonable basis.

On January 11, 2022, the Center for Medicare and Medicaid Services released a draft opinion, stating it would only pay for Aduhelm for patients in a hospital-sponsored clinical trial.

On this news, Biogen’s common stock price fell to close at $225 per share on January 12, 2022. 

INVESTORS WHO HAVE HELD BIOGEN STOCK SINCE AT LEAST JANUARY 2022 ARE ALSO ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected][email protected], TO DISCUSS THE INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

BIOGEN, INC. (NASDAQ: BIIB) BREACH OF FIDUCIARY DUTIES INVESTIGATION

Investigation On Behalf Of Latch Investors Who Held TSIA Stock

Kehoe Law Firm, P.C. is investigating whether certain directors and officers of TS Innovation Acquisitions Corp. (“TSIA”) (NASDAQ: TSIA), now known as Latch, Inc. (“Latch”) (NASDAQ: LTCH), breached their fiduciary duties to TSIA’s shareholders.
INVESTORS OF TS INNOVATION ACQUISITIONS CORP. STOCK WHO NOW HOLD LATCH STOCK SHARES ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS OF THEIR TSIA/LATCH HOLDINGS. 

The investigation concerns whether TSIA’s board of directors or executive officers breached their duties of disclosure, duties of candor, and requirements to act in good faith, and whether TSIA’s shareholders suffered damages as a result.

On June 3, 2021, TSIA shareholders of record as of May 11, 2021 approved a merger between TSIA and Latch’s predecessor company.

On August 25, 2022, after the market closed, Latch revealed that it would restate financial statements for 2021 and the first quarter of 2022 due to revenue recognition errors related to the sale of hardware devices. Specifically, the Company stated that “certain revenue recognition errors occurred as a result of unreported sales arrangements due to sales activity that was inconsistent with the Company’s internal controls and procedures.”

The stock price has declined by over 87% since the merger. 

INVESTORS OF TSIA SECURITIES WHO NOW HOLD LATCH STOCK ARE ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected][email protected], TO DISCUSS THE INVESTIGATION AND POTENTIAL LEGAL CLAIMS.  

INVESTIGATION ON BEHALF OF LATCH (NASDAQ: LTCH) INVESTORS WHO HELD TSIA STOCK

Long-Term Shareholders of Starbucks May Have Legal Claims – SBUX

Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Starbucks Corporation (“Starbucks”) (NASDAQ: SBUX) breached their fiduciary duties to Starbucks and its shareholders.
STARBUCKS SHAREHOLDERS WHO WISH TO DISCUSS POTENTIAL LEGAL CLAIMS ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS ABOUT THEIR STARBUCKS STOCK HOLDINGS. 

The investigation concerns whether members of Starbucks’s board of directors or senior management failed to manage Starbucks in an acceptable manner, in breach of their fiduciary duties, and whether Starbucks and its shareholders have suffered damages as a result.

Starbucks is currently responding to or defending numerous administrative complaints and governmental investigations regarding potentially illegal or otherwise impermissible conduct regarding labor relations at the company.

SHAREHOLDERS OF STARBUCKS MAY HAVE LEGAL CLAIMS AGAINST STARBUCKS’ DIRECTORS AND OFFICERS.  IF YOU WISH TO DISCUSS THE INVESTIGATION OR POTENTIAL LEGAL CLAIMS, PLEASE CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected][email protected]

Starbucks Corporation (NASDAQ: SBUX) Breach of Fiduciary Duties Investigation